Governor Laura Kelly announces largest economic development investment in Kelly administration history

~~$650 million business investment in Kansas economy, 500 new high-paying jobs in Manhattan~~

MANHATTAN- Today, Governor Laura Kelly announced the most significant economic development project of her administration to date. Scorpion Biological Services, a subsidiary of Heat Biologics, Inc., is beginning planned development of a new 500,000 square foot biomanufacturing facility in Kansas. The $650 million business investment project will create 500 new well-paying jobs in Manhattan over the next seven years.

“Kansas is the center of the country, with quick access to either coast, a strong workforce and a growing economy – so there’s no better state for Scorpio than localize to address potential public health threats”, said Governor Laura Kelly. “Scorpion’s choice to locate this facility in the state reinforces what many have come to learn: Kansas is open for business.”

The facility will support the development of vaccines enabling an accelerated response to global biological threats. In addition, the Company intends to provide commercial-level bioanalytical development, manufacturing and testing services at every stage of biopharmaceuticals on a fee-for-service basis to the global healthcare industry.

“We show again and again that we have what it takes to attract highly innovative, highly technical companies to Kansas,” said Lieutenant Governor and Secretary of Commerce David Toland. “It is absolutely essential that we as a nation increase our domestic production capacity for these types of vaccines and we are extremely proud to see this work happening here in Kansas.” Scorpion’s biomanufacturing facility represents a new chapter for the company and opens the door to a more prepared, innovative and resilient future in how our nation – and the world – will respond to biological threats.

The combination of a world-class public research university, innovative private sector partners, and essential national security led Scorpion to choose Manhattan for its new facility. Additionally, the skill and strength of the Kansas workforce will support the success of this project with the brightest minds and hard workers in Kansas joining the effort.

“Today we are very proud to unveil our brand new biofabrication facility in Manhattan, Kansas,” Jeff Wolf, CEO of Heat, said. “With a model that begins with discovery at our subsidiary Skunkworx in North Brunswick, New Jersey and ends with commercial-scale manufacturing here in Manhattan, this facility represents the next step in our evolution, allowing us to combine speed and agility with full integration of discovery, development and manufacturing.

“We are very pleased to inaugurate this new facility. There is a strong demand for world-class biomanufacturing, which is expected to continue in the future. We intend to help meet this demand with our new facility in Manhattan, Kansas. The 500,000 square foot Manhattan facility is designed to service up to 144,000 liters in 48 bioreactors,” David Halverson, president of Heat’s Scorpion subsidiary, said. “Powered by an excellent Kansas workforce, we look forward to seeing Scorpion grow and expand rapidly, and Manhattan is the perfect location for our new facility.

This project was born out of partnerships between the Kansas Department of Commerce, Kansas State University, Kansas State University Innovation Partners, City of Manhattan, Manhattan Chamber of Commerce, Pottawatomie County, Pottawatomie County Economic Development Corporation, Manhattan Area Technical College. , Evergy, CRB and Realty Trust Group.

View additional information and access a live stream of the event here. Photos will be uploaded to this webpage after the announcement event.